Adjusted excess all-cause mortality was 6.8 per 10,000 for Blacks and 1.5 per 10,000 for Whites, with considerable variation across states
First Federal COVID-19 Vaccination Sites to Open in California
One center will be housed in the Oakland Coliseum, another on the campus of California State University, Los Angeles
Blood Lead Level Testing Among Children Decreased During COVID-19
Estimated 9,603 children with elevated BLL were missed due to decreased testing in January to May 2020
Intranasal Flu Shot Candidate Spurs Strong Immune Response
An experimental single-dose, intranasal influenza vaccine candidate, was found safe and produced a durable immune response when tested in a Phase 1 study, announced the National Institutes of Health.
This study was sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) and published in the Journal of Clinical Investigation on February 2, 2021.
Intranasal Flu Shot Candidate Spurs Strong Immune Response
An experimental single-dose, intranasal influenza vaccine candidate, was found safe and produced a durable immune response when tested in a Phase 1 study, announced the National Institutes of Health.
This study was sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) and published in the Journal of Clinical Investigation on February 2, 2021.
COVAX Publishes First Interim COVID-19 Vaccine Distribution Forecast
The Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance, and the World Health Organisation (WHO), as co-leads of the COVAX initiative for equitable global access to COVID-19 vaccines, published COVAX’s first interim COVID-19 vaccine distribution forecast.
About Four in 10 U.S. Adults Skipped Medical Care During Pandemic
Some cited fear of COVID-19 and financial reasons
Biden Administration to Start Shipping COVID-19 Vaccines Directly to U.S. Pharmacies
In addition, starting this week, states are receiving 5 percent more vaccine doses
COVID-19 Vaccine Uptake Moderately High for Residents at SNFs
Median of 77.8 percent of residents and 37.5 percent of staff members per facility received one or more doses of COVID-19 vaccine
AstraZeneca Vaccine Guards Against Severe COVID-19 Illness
Researchers also found that a single dose of the vaccine was 76 percent effective at preventing COVID-19